Natco Pharma Commenced Commercial Production At Visakhapatnam, AP
Natco Pharma Limited has announced for successfully finished dosage formulation (FDF) facility at Visakhapatnam, Andhra Pradesh. This facility is a part of the Special Economic Zone (SEZ) and is intended to cater primarily to the US and other international markets.
The Visakhapatnam facility is a key part of NATCo's capacity expansion plans for its pipeline of products and entry into new geographies. The facility will focus on oral solid dosages (tables & capsules), including a cytotoxic block for products in the oncology segment.